KeyBanc raised the firm’s price target on MKS Instruments to $160 from $150 and keeps an Overweight rating on the shares. The firm walked away from SEMICON West believing the much-awaited cyclical inflection is starting to appear, although the firm doesn’t expect meaningful growth until 2025, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKSI:
- Carvana upgraded, LegalZoom downgraded: Wall Street’s top analyst calls
- MKS Instruments initiated with a Buy at BofA
- MKS Instruments Unveils Strategic Investor Presentation 2024
- MKS Instruments assumed with a Hold at Deutsche Bank
- MKS Instruments Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For